Articles tagged "Kidney/liver transplantation"

2019 American Transplant Congress
BTLA Suppressed Acute Rejection by Regulating T Cell Receptor Downstream Signal Pathways and Cytokine Production in Renal Transplant and Contributed to Prolongation of Allograft Survival
J. Zhang, Z. Wang, S. Fei, H. Chen, L. Sun, Z. Han, J. Tao, X. Ju, R. Tan, M. Gu
No.300 Guangzhou Road of Nanjing, Nanjing, China
*Purpose: The present study aimed to investigate the role of BTLA in the progress of acute rejection after kidney transplantation.*Methods: In human allograft renal transplanted…
2019 American Transplant Congress
Evaluation of Pneumocystis jirovecii Pneumonia Prophylaxis among Kidney and Liver Transplant Recipients; Trimethoprim/Sulfamethoxazole vs Alternative Therapies
E. Aldag, C. Pagels, R. Pedersen, I. Nadeem, V. Gunabushanam, A. Sahajpal, T. J. Dilworth
Aurora St Luke's Medical Center, Milwaukee, WI
*Purpose: To describe Pneumocystis Jirovecii Pneumonia (PJP) prophylaxis (ppx) practices in our transplant recipients and to determine its safety and efficacy.*Methods: Retrospective review of kidney…
2019 American Transplant Congress
The Use of Mobile Software for Real-Time, Secure, Team-Based Procurement and Transplantation Team Communication to Improve the Deceased Donor Organ Transplantation Process
E. Pahl
HealthTech Solutions, Inc., Coralville, IA
*Purpose: Deceased donor organ (DDO) transplantation is an effective cure for patients suffering from organ failure. Organ transplantation is cost-effective, provides a significant survival benefit,…
2019 American Transplant Congress
Delayed Kidney Transplantation in Combined Liver Kidney Transplantation: A Validation Analysis by the UNOS Registry
L. Chau, M. Safwan, M. Rizzari, K. Collins, A. Yoshida, M. Abouljoud, D. Moonka, S. Nagai
Transplant Surgery, Henry Ford Hospital, Detroit, MI
*Purpose: Delayed kidney transplantation for patients undergoing combined liver-kidney transplant (CLKT) have been suggested to improve patient survival and kidney function compared to simultaneous liver-kidney…
2019 American Transplant Congress
Iguratimod Attenuates the Production of Donor Specific Antibody by Inducing CD19⁺Tim-1⁺ Regulatory B Cells and Imbalance of Th17 Treg
Z. Wang, S. Fei, H. Chen, Z. Han, L. Sun, J. Tao, X. Ju, M. Zheng, R. Tan, M. Gu
No.300 Guangzhou Road of Nanjing, Nanjing, China
*Purpose: This study was designed to investigate the effect and mechanisms of Iguratimod on circulating DSA and allograft survival in a skin transplant model.*Methods: Mice…
2019 American Transplant Congress
CMV-Specific Cell-Mediated Immunity Early after Transplantation Discriminates R+ Transplant Patients at Risk of CMV Infection among Different Solid Organ Transplants
M. Jarque¹, A. Cachero², E. Garcia-Romero³, L. Lladó², C. Baliellas², C. Diez³, E. Melilli⁴, J. Fabregat², J. Gonzalez-Costello³, O. Bestard⁴
¹Experimentall Nephrology laboratory, IDIBELL, L'Hospitalet de Llobregat. Barcelona, Spain, ²Liver Transplant Department, Bellvitge University Hospital, L'Hospitalet de Llobregat. Barcelona, Spain, ³Heart Transplant Unit, Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat. Barcelona, Spain, ⁴Kidney Transplantation Unit, Bellvitge University Hospital- IDIBELL, L'Hospitalet de Llobregat. Barcelona, Spain
*Purpose: While monitoring CMV-specific cell-mediated immunity(CMI) has shown to be effective in predicting the risk of CMV infection, comparisons across different solid organ transplants(SOT) and…
2019 American Transplant Congress
Safety and Efficacy of Anti Xa Inhibitors Post-Transplant with Concomitant Calcineurin Inhibitors
K. A. McMurry¹, J. Shuster², K. Bain², T. Horwedel³, J. Hartupee²
¹Michigan Medicine, Ann Arbor, MI, ²Barnes-Jewish Hospital, St. Louis, MO, ³Veloxis Pharmaceuticals, Cary, NC
*Purpose: Despite demonstrated benefits of Anti-Xa Inhibitors (ATIs) in the general population, ATIs have not gained uniform acceptance in SOT due to lack of supportive…
2018 American Transplant Congress
Kidney after Liver Transplant: A Matched Pair Analysis
M. Eerhart, J. Reyes, J. Danobeitia, L. Zitur, P. Chlebeck, L. Fernandez.
Surgery, University of Wisconsin, Madison, WI.
Background: Kidney after liver (KAL) transplantation is the best therapeutic option for patients with ESRD after liver transplantation (OLT). Current allocation policies create a safety…
2018 American Transplant Congress
Analysis of NIH Research Funding in Transplantation: The Important Impact of Physician-Scientists in Abdominal Transplant Research
A. Narahari, J. Mehaffey, A. Chandrabhatla, P. Baderdinni, L. Kron, K. Brayman.
Surgery, University of Virginia, Charlottesville, VA.
Introduction: Obtaining National Institutes of Health (NIH) funding for scientific research has become increasingly difficult. With increasing clinical demands and declining NIH funding, performing research…
2018 American Transplant Congress
Willingness to Accept HIV-Positive and Increased Infectious Risk Donor Organs among HIV-Positive Transplant Candidates
M. Waldram, A. Eno, E. Lee, S. Seaman, A. Nguyen, S. Halpern, S. Anjum, J. Sugarman, M. Henderson, A. Tobian, D. Segev, C. Durand.
JHU, Baltimore.
Implementation of HIV+ to HIV+ organ transplantation under the HOPE Act could shorten waitlist times for HIV+ transplant candidates. However, realizing these potential benefits depends…